Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2018, Article ID 9242616, 15 pages
https://doi.org/10.1155/2018/9242616
Research Article

Thiadiazoline- and Pyrazoline-Based Carboxamides and Carbothioamides: Synthesis and Inhibition against Nitric Oxide Synthase

1Departamento de Química Farmacéutica y Orgánica, Facultad de Farmacia, Universidad de Granada, Campus de Cartuja, s/n, 18071 Granada, Spain
2Departamento de Farmacología, Facultad de Farmacia, Universidad de Granada, Campus de Cartuja, s/n, 18071 Granada, Spain
3CIBERCV, Granada, Spain

Correspondence should be addressed to M. Encarnación Camacho; se.rgu@ohcamace and M. Dora Carrión; se.rgu@noirracd

Received 13 November 2017; Revised 18 December 2017; Accepted 11 January 2018; Published 20 March 2018

Academic Editor: Fabio Polticelli

Copyright © 2018 Fabio Arias et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Poorrajab, S. K. Ardestani, S. Emami, M. Behrouzi-Fardmoghadam, A. Shafiee, and A. Foroumadi, “Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: Synthesis and in vitro biological evaluation,” European Journal of Medicinal Chemistry, vol. 44, no. 4, pp. 1758–1762, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. A. Kadi, E. S. Al-Abdullah, I. A. Shehata, E. E. Habib, T. M. Ibrahim, and A. A. El-Emam, “Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives,” European Journal of Medicinal Chemistry, vol. 45, no. 11, pp. 5006–5011, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Schenone, C. Brullo, O. Bruno et al., “New 1,3,4-thiadiazole derivatives endowed with analgesic and anti-inflammatory activities,” Bioorganic & Medicinal Chemistry, vol. 14, no. 6, pp. 1698–1705, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Gupta, P. Mishra, S. K. Kashaw, V. Jatav, and J. P. Stables, “Synthesis and anticonvulsant activity of some novel 3-aryl amino/amino-4-aryl-5-imino-Δ2-1,2,4-thiadiazoline,” European Journal of Medicinal Chemistry, vol. 43, no. 4, pp. 749–754, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. U. F. Mansoor, A. R. Angeles, C. Dai et al., “Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitors,” Bioorganic & Medicinal Chemistry, vol. 23, no. 10, pp. 2424–2434, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. C. De Monte, S. Carradori, D. Secci et al., “Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma,” European Journal of Medicinal Chemistry, vol. 105, pp. 245–262, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Insuasty, A. García, J. Quiroga et al., “Efficient microwave-assisted synthesis and antitumor activity of novel 4,4-methylenebis[2-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)phenols],” European Journal of Medicinal Chemistry, vol. 46, no. 6, pp. 2436–2440, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Insuasty, A. Tigreros, F. Orozco et al., “Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents,” Bioorganic & Medicinal Chemistry, vol. 18, no. 14, pp. 4965–4974, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M.-Y. Zhao, Y. Yin, X.-W. Yu et al., “Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAFV600E inhibitors,” Bioorganic & Medicinal Chemistry, vol. 23, no. 1, pp. 46–54, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. F. F. Barsoum and A. S. Girgis, “Facile synthesis of bis(4,5-dihydro-1H-pyrazole-1-carboxamides) and their thio-analogues of potential PGE2 inhibitory properties,” European Journal of Medicinal Chemistry, vol. 44, no. 5, pp. 2172–2177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. Özdemir, H. B. Kandilci, B. Gümüşel, Ü. Çaliş, and A. A. Bilgin, “Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives,” European Journal of Medicinal Chemistry, vol. 42, no. 3, pp. 373–379, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Secci, S. Carradori, A. Bolasco, B. Bizzarri, M. D'Ascenzio, and E. Maccioni, “Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors,” Current Topics in Medicinal Chemistry, vol. 12, no. 20, pp. 2240–2257, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Özdemir, G. Turan-Zitouni, Z. Asim Kaplancikli, G. Revial, and K. Güven, “Synthesis and antimicrobial activity of 1-(4-aryl-2-thiazolyl)-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives,” European Journal of Medicinal Chemistry, vol. 42, no. 3, pp. 403–409, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Ramírez–Prada, S. M. Robledo, I. D. Vélez et al., “Synthesis of novel quinoline–based 4,5–dihydro–1H–pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents,” European Journal of Medicinal Chemistry, vol. 131, pp. 237–254, 2017. View at Publisher · View at Google Scholar · View at Scopus
  15. L. C. López Cara, M. E. Camacho, M. D. Carrión et al., “Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors,” European Journal of Medicinal Chemistry, vol. 44, no. 6, pp. 2655–2666, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. D. Carrión, M. Chayah, A. Entrena et al., “Synthesis and biological evaluation of 4,5-dihydro-1H-pyrazole derivatives as potential nNOS/iNOS selective inhibitors. Part 2: Influence of diverse substituents in both the phenyl moiety and the acyl group,” Bioorganic & Medicinal Chemistry, vol. 21, no. 14, pp. 4132–4142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. D. Carrión, L. C. López Cara, M. E. Camacho et al., “Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III),” European Journal of Medicinal Chemistry, vol. 43, no. 11, pp. 2579–2591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Castaño, A. Encinas, C. Pérez, A. Castro, N. E. Campillo, and C. Gil, “Design, synthesis, and evaluation of potential inhibitors of nitric oxide synthase,” Bioorganic & Medicinal Chemistry, vol. 16, no. 11, pp. 6193–6206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Harish, P. G. Satya, A. S. Anees, and K. Vijay, “Advances in design and development of inhibitors of nitric oxide synthases,” Current Enzyme Inhibition, vol. 9, no. 2, pp. 117–141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Yamasaki and M. F. Cohen, “Biological consilience of hydrogen sulfide and nitric oxide in plants: Gases of primordial earth linking plant, microbial and animal physiologies,” Nitric Oxide: Biology and Chemistry, vol. 55-56, pp. 91–100, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Karpuzoglu and S. A. Ahmed, “Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: Implications for immunity, autoimmune diseases, and apoptosis,” Nitric Oxide: Biology and Chemistry, vol. 15, no. 3, pp. 177–186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J. D. Allen, T. Giordano, and C. G. Kevil, “Nitrite and nitric oxide metabolism in peripheral artery disease,” Nitric Oxide: Biology and Chemistry, vol. 26, no. 4, pp. 217–222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Singh and A. K. Gupta, “Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies,” Cancer Chemotherapy and Pharmacology, vol. 67, no. 6, pp. 1211–1224, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Napoli and L. J. Ignarro, “Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases,” Archives of Pharmacal Research, vol. 32, no. 8, pp. 1103–1108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Ashina, L. Bendtsen, and M. Ashina, “Pathophysiology of tension-type headache,” Current Pain and Headache Reports, vol. 9, no. 6, pp. 415–422, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. O. Bingham III, “The pathogenesis of rheumatoid arthritis: Pivotal cytokines involved in bone degradation and imflammation,” The Journal of Rheumatology, vol. 29, no. 65, pp. 3–9, 2002. View at Google Scholar · View at Scopus
  27. S. Singh and M. Dikshit, “Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide,” Brain Research Reviews, vol. 54, no. 2, pp. 233–250, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Malinski, “Nitric oxide and nitroxidative stress in Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 11, no. 2, pp. 207–218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Aguilera, M. E. Chánez-Cárdenas, E. Floriano-Sánchez et al., “Time-related changes in constitutive and inducible nitric oxide synthases in the rat striatum in a model of Huntington's disease,” NeuroToxicology, vol. 28, no. 6, pp. 1200–1207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Napoli and L. J. Ignarro, “Nitric oxide and atherosclerosis,” Nitric Oxide: Biology and Chemistry, vol. 5, no. 2, pp. 88–97, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. L. C. López-Cara, M. D. Carrión, A. Entrena et al., “1,3,4-Thiadiazole derivatives as selective inhibitors of iNOS versus nNOS: Synthesis and structure-activity dependence,” European Journal of Medicinal Chemistry, vol. 50, pp. 129–139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. E. Camacho, J. León, A. Entrena et al., “4,5-Dihydro-1H-pyrazole derivatives with inhibitory nNOS activity in rat brain: Synthesis and structure - Activity relationships,” Journal of Medicinal Chemistry, vol. 47, no. 23, pp. 5641–5650, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Chayah, M. D. Carriõn, M. A. Gallo, R. Jiménez, J. Duarte, and M. E. Camacho, “Development of urea and thiourea kynurenamine derivatives: Synthesis, molecular modeling, and biological evaluation as nitric oxide synthase inhibitors,” ChemMedChem, vol. 10, no. 5, pp. 874–882, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Chayah, M. E. Camacho, M. D. Carrión, M. A. Gallo, M. Romero, and J. Duarte, “N, N -Disubstituted thiourea and urea derivatives: Design, synthesis, docking studies and biological evaluation against nitric oxide synthase,” MedChemComm, vol. 7, no. 4, pp. 667–678, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Maccallini, M. Montagnani, R. Paciotti et al., “Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies,” ACS Medicinal Chemistry Letters, vol. 6, no. 6, pp. 635–640, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Mukherjee, M. A. Cinelli, S. Kang, and R. B. Silverman, “Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain,” Chemical Society Reviews, vol. 43, no. 19, pp. 6814–6838, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. J. S. Fortin, J. Lacroix, M. Desjardins, A. Patenaude, É. Petitclerc, and R. C.-Gaudreault, “Alkylation potency and protein specificity of aromatic urea derivatives and bioisosteres as potential irreversible antagonists of the colchicine-binding site,” Bioorganic & Medicinal Chemistry, vol. 15, no. 13, pp. 4456–4469, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Janiak, S. Deblon, and H.-P. Wu, “Syntheses of 5,5-disubstituted 2,2'-bipyridines,” Synthetic Communications, vol. 29, no. 19, pp. 3341–3352, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. D. S. Bredt and S. H. Snyder, “Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 87, no. 2, pp. 682–685, 1990. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Jiménez, M. Sánchez, M. J. Zarzuelo et al., “Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor β agonists via the phosphatidyl-inositol-3 kinase-Akt pathway,” The Journal of Pharmacology and Experimental Therapeutics, vol. 332, no. 2, pp. 554–561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. Z. Ungvari, D. Sun, A. Huang, G. Kaley, and A. Koller, “Role of endothelial [Ca2+]i in activation of eNOS in pressurized arterioles by agonists and wall shear stress,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 281, no. 2, pp. H606–H612, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Pfeiffer, E. Leopold, K. Schmidt, F. Brunner, and B. Mayer, “Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine,” British Journal of Pharmacology, vol. 118, no. 6, pp. 1433–1440, 1996. View at Publisher · View at Google Scholar